- Our Services
-
Patients and Families
- Get Directions
- Parking
- Childrens Locations
- Getting Around
- Guidelines for Visitors
- Contact a Patient
- Contact Children's
- Send an e-Card
- Gift Shop
Planning a Visit
- Find a Doctor
- Make an Appointment
- Child Health A-Z
- Community Ed.Classes
- Injury Prevention
- International Patients
- Medical Records
- Patient Handbook
- Patient Procedures
Parents
- For Health Professionals
- Research
- Ways to Give
- News
Child Abuse Expert Appointed to Task Force
Dr. Hackam Receives Award to Generate an Artificial Intestine
International Expert Named Chief of Ophthalmology News Releases
News Releases
For Immediate Release
World's Leading Experts on Neonatal Jaundice Discuss Causes, Treatments, Outcomes and Prevention on Live Web Cast
Pittsburgh, Pa. -
September 6, 2006
-
WHO: Jon F. Watchko, MD, Division of Newborn Medicine, Children's Hospital of Pittsburgh/Magee-Womens Hospital
Gary A. Silverman, MD, PhD, Chief of the Division of Newborn Medicine, Children's Hospital of Pittsburgh/Magee-Womens Hospital
M. Jeffrey Maisels, MBBCh, Chair of Pediatrics, William Beaumont Hospital, Royal Oak, Mich.
John LaBella, MD, Pediatrician, Children's Community Pediatrics - Bass Wolfson
WHAT: These internationally recognized experts in newborn medicine will present the latest information on hyperbilirubinemia, also known as neonatal jaundice. Drs. Watchko and Maisels will discuss causes, care, outcomes and prevention of severe neonatal jaundice. Following their presentation, Dr. Silverman will moderate a discussion - joined by Dr. LaBella - on the latest treatments and take questions from both the live audience and the Web audience.
This Continuing Medical Education (CME) event also will be available via live Web cast through Children's Web site at www.chp.edu
WHY: Jaundice - one of the most common conditions affecting newborns - is a yellowing of the skin and eyes that is caused by an elevated bilirubin level in the blood. Bilirubin accumulates when red blood cells break down.
Neonatal jaundice affects 60 percent of full-term infants and 80 percent of preterm infants in the first several days after birth. Early detection and treatment of jaundice is crucial to preventing the bilirubin levels from rising to dangerous levels. Extremely high levels can lead to bilirubin-induced brain damage, a condition known as kernicterus.
WHEN: Thursday, Sept. 21, 2006, at 8 a.m.
Options for Attending: Children's Hospital of Pittsburgh, 3705 Fifth Ave., Pittsburgh, Pa.
Registration for the live Web cast, and the post-event archived session, is available through Children's at http://www.or-live.com/cpi/1555/.
Contacts:
Marc Lukasiak, 412-692-7919 or 412-692-5016, Marc.Lukasiak@chp.edu
Melanie Finnigan, 412-692-5502 or 412-692-5016, Melanie.Finnigan@chp.edu
Last Update
June 11, 2008
June 11, 2008
